Lithium and suicide prevention in mood disorders and in the general population: A systematic review.

Antimanic Agents / therapeutic use Bipolar Disorder / drug therapy Humans Lithium / therapeutic use Mood Disorders / drug therapy Prospective Studies Retrospective Studies Suicide Prevention
Bipolar disorder Drinking Water Lithium Major depressive disorder Recurrent depressive disorder Schizoaffective disorder Suicide

Journal

Neuroscience and biobehavioral reviews
ISSN: 1873-7528
Titre abrégé: Neurosci Biobehav Rev
Pays: United States
ID NLM: 7806090

Informations de publication

Date de publication:
09 2020
Historique:
received: 19 12 2019
revised: 06 04 2020
accepted: 10 06 2020
pubmed: 21 6 2020
medline: 22 6 2021
entrez: 21 6 2020
Statut: ppublish

Résumé

Suicide contributes to 1-4 % of deaths worldwide every year. We conducted a systematic review aimed at summarizing evidence on the use of lithium for the prevention of suicide risk both in mood disorders and in the general population. We followed the PRISMA methodology (keywords: "lithium", "suicide" AND "suicidal" on Pubmed, Cochrane CENTRAL, Clinicaltrial.gov, other databases). Inclusion criteria: lithium therapy in mood disorder or found in drinking water or scalp in the general population. Exclusion criteria: no lithium administration. From 918 screened references, 18 prospective (number of participants: 153786), 10 retrospective (number of participants: 61088) and 16 ecological studies (total sample: 2062) were included. Most of the observational studies reported a reduction in suicide in patients with mood disorders. All studies about lithium treatment's duration reported that long-term lithium give more benefits than short-term lithium in suicide risk The evidence seems to attribute an intrinsic anti-suicidal property of lithium, independent of its proven efficacy as a mood stabilizer.

Identifiants

DOI: 10.1016/j.neubiorev.2020.06.017 PMID: 32561344
pubmed: 32561344
pii: S0149-7634(20)30444-9
doi: 10.1016/j.neubiorev.2020.06.017
pii:
doi:

Substances chimiques

Antimanic Agents 0
Lithium 9FN79X2M3F

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

142-153

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Auteurs

L Del Matto (L)

Department of Molecular Medicine, University of Siena School of Medicine and Department of Mental Health, University of Siena Medical Center (AOUS), Viale Mario Bracci 16, 53100, Siena, Italy.

M Muscas (M)

Section of Psychiatry, Department of Medical Sciences and Public Health, University of Cagliari, Italy.

A Murru (A)

Bipolar Disorders and Depressive Unit, Institute of Neuroscience, Hospital Clínic, University of Barcelona, iDiBAPS, CiBeRSAM, Barcelona, Catalonia, Spain.

N Verdolini (N)

Bipolar Disorders and Depressive Unit, Institute of Neuroscience, Hospital Clínic, University of Barcelona, iDiBAPS, CiBeRSAM, Barcelona, Catalonia, Spain.

G Anmella (G)

Bipolar Disorders and Depressive Unit, Institute of Neuroscience, Hospital Clínic, University of Barcelona, iDiBAPS, CiBeRSAM, Barcelona, Catalonia, Spain.

G Fico (G)

Department of Psychiatry, University of Campania Luigi Vanvitelli, Largo Madonna delle Grazie, 80139, Naples, Italy.

F Corponi (F)

Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.

A F Carvalho (AF)

Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Centre of Addiction and Mental Health (CAMH), Toronto, ON, Canada.

L Samalin (L)

CHU Clermont-Ferrand, Department of Psychiatry, EA 7280, Clermont-Ferrand University, Clermont-Ferrand, France.

B Carpiniello (B)

Section of Psychiatry, Department of Medical Sciences and Public Health, University of Cagliari, Italy.

A Fagiolini (A)

Department of Molecular Medicine, University of Siena School of Medicine and Department of Mental Health, University of Siena Medical Center (AOUS), Viale Mario Bracci 16, 53100, Siena, Italy.

E Vieta (E)

Bipolar Disorders and Depressive Unit, Institute of Neuroscience, Hospital Clínic, University of Barcelona, iDiBAPS, CiBeRSAM, Barcelona, Catalonia, Spain. Electronic address: evieta@clinic.cat.

I Pacchiarotti (I)

Bipolar Disorders and Depressive Unit, Institute of Neuroscience, Hospital Clínic, University of Barcelona, iDiBAPS, CiBeRSAM, Barcelona, Catalonia, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Agents du système nerveux central › Psychoanaleptiques › Tranquillisants › Antimaniacodépressifs › Lithium and suicide prevention in mood...
questionsmedicales.fr › Troubles mentaux › Troubles de l'humeur › Troubles bipolaires et apparentés › Trouble bipolaire › Lithium and suicide prevention in mood...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Lithium and suicide prevention in mood...
questionsmedicales.fr › Produits chimiques inorganiques › Métaux › Métaux légers › Lithium › Lithium and suicide prevention in mood...
questionsmedicales.fr › Troubles mentaux › Troubles de l'humeur › Lithium and suicide prevention in mood...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Études prospectives › Lithium and suicide prevention in mood...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Études rétrospectives › Lithium and suicide prevention in mood...
questionsmedicales.fr › Établissements, main d'oeuvre et services de soins de santé › Services de santé › Services de médecine préventive › Prévention du suicide › Lithium and suicide prevention in mood...